U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804993) titled 'Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial' on Jan. 28.
Brief Summary: This is a single-centre, prospective randomized controlled trial on female patients with anterior rectocele associated with obstructed defecation syndrome
Study Start Date: July 31, 2021
Study Type: INTERVENTIONAL
Condition:
Obstructed Defaecation Syndrome
Anterior Rectocele
Intervention:
DRUG: Transvaginal repair & botulinum toxin type A injection
100 units of lyophilized botulinum toxin type A were diluted in saline to 50 U/mL before the injections. A total of 30 units of type-A botulinum ...